Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Incyte Capital

1.Incyte Capital, LLC   (100%):
Incyte Capital, together with its affiliate Incyte Capital Partners, LLC, is a highly-focused turnaround private equity fund that seeks control investments and recapitalization buyouts in medium-sized established public and private companies. Unlike most private equity funds in the United States to...
2.Incyte Capital, LLC   (100%):
Incyte Capital, together with its affiliate Incyte Capital Partners, LLC, is a highly-focused turnaround private equity fund that seeks control investments and recapitalization buyouts in medium-sized established public and private companies. Unlike most private equity funds in the United States to...
3.Incyte Capital, LLC   (100%):
Incyte Capital, together with its affiliate Incyte Capital Partners, LLC, is a highly-focused turnaround private equity fund that seeks control investments and recapitalization buyouts in medium-sized established public and private companies. Unlike most private equity funds in the United States to...
4.Incyte Capital, LLC   (84%):
Member Carridine C. Say Senior Associate Ms. Say is a Senior Associate with Incyte Capital and is responsible for analyzing, executing and monitoring all investments in Incyte's portfolio. Prior to joining Incyte, Ms. Say was a financial analyst in the corporate finance department of Deutsche Banc A...
5.Incyte Capital, LLC   (82%):
About Incyte Incyte Capital, LLC considers investments throughout the U.S. and Canada. Incyte employs a focused, partner intensive approach intended to result in measurable benefits to existing investors and management well beyond the providing of capital. The fund seeks control investments in turna...
6.Incyte Capital, LLC   (82%):
Restructuring Assessment Program In certain cases, as a preliminary activity to making a formal investment decision, Incyte makes available to prospective investment candidates its extensive restructuring expertise as an assessment tool. This assessment includes a tactical and strategic review of re...
7.Incyte Capital, LLC   (78%):
Portfolio Companies Recent News for Portfolio Companies Paging Network of Canada Inc. Paging Network of Canada Inc. ("PageNet"), founded in 1996 and based in Toronto, is one of Canada's leading paging companies. Through its 26 terminals, 320 transmitters, four regional offices and fully fu...
8.Incyte Capital, LLC   (72%):
Investment Criteria Incyte Capital considers investments throughout the U.S. and Canada in companies in any industry sector, with particular interest in telecommunications, developed technology and software, healthcare, selected energy, basic industries and selected consumer products. What sets Incy...
9.Incyte Capital, LLC   (58%):
Portfolio Announcements December 10, 2002 - Incyte Capital Investor Group Acquires Credit Facilities May 21, 2003 - SmartSynch Expands Reach to Canadian Power Market December 31, 2003 - Incyte Capital Investor Group Completes Balance Sheet Restructuring with Exchange of Virtually All Debt to Equity ...
10.Incyte Capital, LLC   (57%):
Contact Us Incyte Capital welcomes inquiries from company management, Board members, equity partners and sponsors, and senior lenders. You may reach us at either our New York or San Francisco office. San Francisco Office Location Map San Francisco (downtown) Incyte Capital, LLC 388 Market Street Sui...
11.Bay City Capital - Directors   (51%):
Fred Craves, PhD , is founder and Managing Director of Bay City Capital. Dr. Craves chairs BCC's Executive Committee and serves on its Board of Directors. Prior to founding Bay City Capital, Dr. Craves spent over 20 years leading and managing biotechnology and pharmaceutical companies. He was Execu...
12.Bay City Capital - Venture Partners   (50%):
William G. Gerber, MD , is a Partner at Bay City Capital and joined the company in September, 1999. He was most recently President and Chief Executive Officer of Epoch BioSciences and Chairman of the Board of Directors of Pathway Diagnostics. Prior to joining Epoch, Dr. Gerber served as President a...
13.Incyte Capital, LLC   (47%):
Member Marc A. Gineris Managing Member Articles and Appearances / Restructuring Expertise Mr. Gineris is the Managing Member and Founder of Incyte Capital. He has 20 years of experience in raising capital for, investing in and working closely with the senior management of middle market companies. He...
14.Incyte Capital, LLC   (42%):
Highlights At A Glance Founded in early 2000, Incyte Capital, LLC is a first-of-its-kind private equity capital fund focusing on a unique niche: growth and mid-stage restarts. The firm invests in solid, existing middle-market companies whose growth has stalled, and provide the capital and managerial...
15.CHL Medical Partners   (41%):
overview Jeffrey J. Collinson Timothy F. Howe Ronald W. Lennox Gregory M. Weinhoff Myles D. Greenberg Goga Vukmirovic Michael J. Flaim Jeffrey J. Collinson Jeff has been investing as a venture capitalist since 1972, when he joined the first Schroder venture capital operation, where he became Preside...
16.Aurora Funds   (22%):
Aurora News • 2005 • 2004 • 2003 • 2002 Portfolio Company News Newsletters Events Douglas Gooding joins Regado Biosciences as President Takes President Position with Aurora Portfolio Company; Transitions From Principal to Venture Partner Research Triangle Park, N.C. (November 18,...
17.Aurora Funds   (19%):
Investment Team • Scott Albert • Jeff Clark • Rich Brown • Grant Jackson • Chris Kroeger • Jan Bouten Administrative Team • Lisa Lavallee • Colleen Suite • Sue Simon • Mike Gorman Venture Partners • Doug Gooding • Richard Holcomb • Tho...
18.InterWest Partners - Investing in Information Technology & Life Sciences   (19%):
Partners Principals EiRs & Consultants Advisory Committee Life Sciences Advisory Advisory Committee The InterWest Partners Advisory Committee is a highly experienced team of business professionals, comprising an invaluable resource for both InterWest and our portfolio companies. They assist in the s...
19.Aurora Funds   (17%):
Aurora News • 2005 • 2004 • 2003 • 2002 Portfolio Company News Newsletters Events VC firm looking for biotech deals Staff Writer From the December 5, 2003 print edition of the Atlanta Business Chronicle A North Carolina venture capital heavyweight has sent an investment scout to ...
20.CHL Medical Partners   (15%):
recent news chl medical partners 2003 portfolio companies links to portfolio company news Collinson Howe and Lennox 2001 Newsletter The last twelve months have been very active for our firm, highlighted by: The closing of our fifth fund, the $160 million CHL Medical Partners II, L.P., exceeding our ...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others